The FDA has granted approval for an innovative epinephrine nasal spray, making it the first needle-free emergency treatment for potentially fatal allergic reactions.

The pharma industry shows strong growth into the second quarter of 2024, with companies reporting substantial YoY profit increases in Q2.

Elon Musk’s Neuralink has implanted its brain implant into a new patient, making them the second person to take part in the trial.

Catch up on the top pharma news stories of July in EMJ GOLD’s monthly round-up, including insights on pharma’s use of social media.

The weight loss drug reduces the risk of hospitalisation, death and more for adults with obesity and a common form of heart failure.

BMS has been a vocal opponent of drug price negotiations under the US’ Inflation Reduction Act, but a price preview may have allayed fears.

Researchers and pharmaceutical companies could get wider access to NHS data for the first time under new Labour plans.

With avian influenza posing an ongoing public health threat, a new initiative has been launched to better prepare low- and middle-income countries.